Plain-English translation of NCT07400809 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study—meaning researchers are collecting real-world information from patients with cervical cancer that has returned or spread to a few sites. The study looks at how different combinations of treatments, including radiation therapy, chemotherapy, immunotherapy, or surgery, affect survival outcomes and quality of life. This research helps doctors understand which patients benefit most from adding radiation or other local treatments to their care.
When cervical cancer returns or spreads, chemotherapy alone hasn't always been enough to help patients live longer. Recent evidence suggests that some patients with cancer spread to only a few locations might live longer if doctors add radiation therapy or surgery to treat those specific spots, but there isn't yet clear guidance on the best approach for cervical cancer patients.
You likely qualify if…
You likely don't qualify if…
Your participation is passive—you won't need to visit a clinic or receive new treatment. Researchers at your hospital will collect information from your existing medical records and enter it securely into a centralized database. This includes details about your cancer diagnosis, the treatments you received, how you responded, and any side effects you experienced. The study involves no additional procedures or visits for you.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
India